Page 74 - Read Online
P. 74

Poznyak et al. Microbiome Res Rep. 2026;5:3                                      Page 21 of 23





               147. Tajik N, Frech M, Schulz O, et al. Targeting Zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun.
                  2020;11:1995. DOI PubMed PMC
               148. Veres-Székely A, Szász C, Pap D, Szebeni B, Bokrossy P, Vannay Á. Zonulin as a potential therapeutic target in microbiota-gut-brain
                  axis disorders: encouraging results and emerging questions. Int J Mol Sci. 2023;24:7548. DOI PubMed PMC
               149. Brandl C, Bucci L, Schett G, Zaiss MM. Crossing the barriers: revisiting the gut feeling in rheumatoid arthritis. Eur J Immunol.
                  2021;51:798-810. DOI PubMed
               150. Shan L, Chelliah R, Rahman SME, Hwan Oh D. Unraveling the gut microbiota’s role in Rheumatoid arthritis: dietary pathways to
                  modulation and therapeutic potential. Crit Rev Food Sci Nutr. 2025;65:3291-301. DOI PubMed
               151. Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol. 2016;9:229-39. DOI
                  PubMed PMC
               152. Arora U, Kedia S, Ahuja V. The practice of fecal microbiota transplantation in inflammatory bowel disease. Intest Res. 2024;22:44-64.
                  DOI PubMed PMC
               153. Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The use of fecal microbiome transplant in treating human diseases: too early for
                  poop? Front Microbiol 2021;12:519836. DOI PubMed PMC
               154. Belvoncikova P, Maronek M, Gardlik R. Gut dysbiosis and fecal microbiota transplantation in autoimmune diseases. Int J Mol Sci.
                  2022;23:10729. DOI PubMed PMC
               155. Hamamah S, Gheorghita R, Lobiuc A, Sirbu IO, Covasa M. Fecal microbiota transplantation in non-communicable diseases: recent
                  advances and protocols. Front Med (Lausanne). 2022;9:1060581. DOI PubMed PMC
               156. Kragsnaes MS, Kjeldsen J, Horn HC, et al. Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic
                  arthritis: an exploratory randomised placebo-controlled trial. Ann Rheum Dis. 2021;80:1158-67. DOI PubMed
               157. Seida I, Al Shawaf M, Mahroum N. Fecal microbiota transplantation in autoimmune diseases - An extensive paper on a pathogenetic
                  therapy. Autoimmun Rev. 2024;23:103541. DOI PubMed
               158. Lu C, Chen J, Yi C, et al. Gut microbiota mediated the protective effects of tuna oil on collagen-induced arthritis in mice. Food Funct.
                  2021;12:5387-98. DOI
               159. Profir M, Roşu OA, Creţoiu SM, Gaspar BS. Friend or foe: exploring the relationship between the gut microbiota and the pathogenesis
                  and treatment of digestive cancers. Microorganisms. 2024;12:955. DOI PubMed PMC
               160. Ivashkin V, Poluektov Y, Kogan E, et al. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins
                  expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome. PLoS One.
                  2021;16:e0252930. DOI PubMed PMC
               161. Bagheri S, Zolghadri S, Stanek A. Beneficial effects of anti-inflammatory diet in modulating gut microbiota and controlling obesity.
                  Nutrients. 2022;14:3985. DOI PubMed PMC
               162. Luo Y, Tong Y, Wu L, et al. Alteration of gut microbiota in individuals at high-risk for rheumatoid arthritis associated with disturbed
                  metabolome and the initiation of arthritis through the triggering of mucosal immunity imbalance. Arthritis Rheumatol. 2023;75:1736-48.
                  DOI PubMed
               163. Zeng L, Deng Y, Yang K, Chen J, He Q, Chen H. Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and
                  autoinflammatory diseases: a systematic review and meta-analysis. Front Immunol. 2022;13:944387. DOI PubMed PMC
               164. Cold F, Svensson CK, Petersen AM, Hansen LH, Helms M. Long-term safety following faecal microbiota transplantation as a treatment
                  for recurrent Clostridioides difficile infection compared with patients treated with a fixed bacterial mixture: results from a retrospective
                  cohort study. Cells. 2022;11:435. DOI PubMed PMC
               165. Ooijevaar RE, van Nood E, Goorhuis A, et al. Ten-year follow-up of patients treated with fecal microbiota transplantation for recurrent
                  Clostridioides difficile infection from a randomized controlled trial and review of the literature. Microorganisms. 2021;9:548. DOI
                  PubMed PMC
               166. Quaranta G, Guarnaccia A, Fancello G, et al. Fecal microbiota transplantation and other gut microbiota manipulation strategies.
                  Microorganisms. 2022;10:2424. DOI PubMed PMC
               167. Mitsou EK, Katsagoni CN, Janiszewska K. Knowledge of dietitians on gut microbiota in health-an online survey of the European
                  federation of the associations of dietitians (EFAD). Nutrients. 2024;16:621. DOI PubMed PMC
               168. Dai Z, Cheng W, Peng H, et al. Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model. Front
                  Immunol. 2025;16:1635244. DOI PubMed PMC
               169. Haq S, Grondin J, Banskota S, Khan WI. Autophagy: roles in intestinal mucosal homeostasis and inflammation. J Biomed Sci.
                  2019;26:19. DOI PubMed PMC
               170. Zhao J, Duan L, Li J, et al. New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic
                  syndrome. Biomed Pharmacother. 2024;176:116807. DOI
   69   70   71   72   73   74   75   76   77   78   79